Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse
Between the Biotech Waves
The Resilience of the IPO Market
There's an element of is it the markets maturing given the developments, the approvals and revenues that were seen coming through. Are we seeing that level of maturity? Do you think nabbing reflected in it? And we're not going to see another exuberance from an IPO market in the next time this opens up or do you think this is going to be rinse repeat? It's going to happen again.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
